How an Amicus Move Recast BioMarin’s Investment Case Overnight
A sudden Amicus development forced investors to reassess BioMarin's pipeline and valuation, changing market assumptions about competition, timing, and future cash flows.
Seeking Alpha
2 min read
Stocks
Biotechnology
Market Analysis